DunedinPACE Epigenetic Clock Predicts Metabolic Syndrome 7 Years Before Onset
New study shows DunedinPACE aging biomarker can predict who will develop metabolic syndrome years in advance, outperforming other epigenetic clocks.
4931 articles
New study shows DunedinPACE aging biomarker can predict who will develop metabolic syndrome years in advance, outperforming other epigenetic clocks.
Men with Klinefelter syndrome (XXY) show reduced epigenetic aging compared to typical XY males, challenging assumptions about chromosome disorders.
Leading researchers identify key challenges in validating aging biomarkers for clinical use, emphasizing need for longitudinal studies.
Study of 2,366 women shows biological aging markers predict future increases in tau, amyloid, and neuroinflammation proteins linked to dementia.
New research explores how epigenetic modifications control the aging process and potential therapeutic targets.
New research reveals how a mitochondrial enzyme enhances immune cell function to fight bacterial lung infections and reduce inflammation.
German registry reveals physicians start most patients on lower-than-recommended doses of new long-acting growth hormone therapies.
Scientists develop bacteria that colonize tumors and secrete proteins to highlight cancer tissue with 15x better contrast than current methods.
Targeting CXCR4 protein improved lung function and reduced heart damage in early COPD mouse models, suggesting new therapeutic approach.
New study shows combining PET scans with blood DNA tests can identify follicular lymphoma patients at high risk of early relapse.
New study reveals mitochondrial NAD+ concentration, not total cellular levels, determines how fast the liver can regenerate after injury.
Comprehensive review reveals emerging clinical evidence for NAD+ precursors in treating age-related diseases and cognitive decline.